MedPath

Cost effectiveness analysis Telemonitoring in Heart Failure

Completed
Conditions
heart failure - heart decompensation
10082206
Registration Number
NL-OMON30939
Lead Sponsor
Academisch Ziekenhuis Maastricht
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
390
Inclusion Criteria

Patient > 18 years;
Patients with heart failure NYHA classification II-III-IV;
patient experienced a period of fluid retention;
Patient is treated by a cardiologist;
Patient is followed-up by a heart failure nurse;
Adequate level of the Dutch language;
Patient has an active telephone connection, preferably analogue ;
Patient is mental competent;
Patient has the disposal of a balance.

Exclusion Criteria

Patients suffers from COPD, Gold classification 3 or 4
patient is a dialysis patient;
Patient has a visual restriction to read the dialogues on the Health Buddy;
Patient is hard of hearing or deaf;
Patient suffers from a lethal sickness with a prognosis < 1 year;
Patient participates in another trial;
Patient needs a hospital admission on short time, i.e. < 3 months;
Patient used the Health Buddy in an earlier stage;
Patient is an illiterate person.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Hospital admissions.<br /><br>Health care related costs</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Related at outcome:<br /><br>· amount of planned and unplanned contacts with cardiologist, heart failure<br /><br>nurse, cardiac emergency and general practitioner;<br /><br>. amount of hospital admissions ( related and not related to heart failure)<br /><br>· mortality (cardiac reason or not )<br /><br>· costs related to hospital admissions and contacts with caregivers<br /><br><br /><br>Related at intervention:<br /><br>· Compliance for drugs and non-medical regimen;<br /><br>. State of health in terms of complaints ( tiredness and dyspnoea), risk<br /><br>factors ( smoking, obesity, drink), instability, mobility, depression, self<br /><br>efficacy and quality of live</p><br>
© Copyright 2025. All Rights Reserved by MedPath